Skip to main content
Medically Approved

Get the latest on the coronavirus vaccines

twitter share buttonfacebook share buttonlinkedin share buttonemail article button
Updated on April 28, 2021

Get the latest on the coronavirus vaccines

Since the start of the worldwide pandemic in early 2020, researchers have been working hard to develop COVID-19 vaccines. Currently, more than 81 vaccines are in clinical development by researchers across the globe. The hope is that multiple ones will work in fighting the coronavirus. Developing a vaccine requires multiple steps, during which researchers test to confirm that the vaccine is safe and that it works. These steps are:

  • Preclinical: Vaccines are not yet ready to be tested on humans (there are currently 182 vaccines in this stage)
  • Phase I: A safety trial where the vaccine is tested on a few people
  • Phase II: Expanded trials including a variety of people
  • Phase III: Efficacy trials including thousands of people, with comparisons to a placebo group
  • Approval: Regulators review the results of phases I through III and approve or deny the use of the vaccine

As COVID-19 vaccines are authorized and then recommended for use in the United States, it is important to understand the information available about each vaccine. The Centers for Disease Control and Prevention (CDC) provides guidance and recommendations about who should receive the vaccines, what to expect after vaccination, as well as information about ingredients, safety and effectiveness.

To keep up to date on the current recommendations, bookmark the CDC website and check it regularly.

Currently, the following vaccines are approved by the U.S. Food and Drug Administration (FDA) for use in preventing COVID-19:

  • Pfizer-BioNTech’s COVID-19 vaccine
  • Moderna’s COVID-19 vaccine
  • Johnson & Johnson’s COVID-19 vaccine

Both the Pfizer-BioNTech and Moderna vaccines require 2 doses, given 21 to 28 days apart. Both are mRNA vaccines. The Johnson & Johnson shot is a viral vector vaccine. It requires only 1 dose. Learn more about the different types of vaccines below.

Types of coronavirus vaccines

When talking about vaccines, it helps to know how our bodies fight infections. When foreign cells — like a virus — enter your body, your immune system responds by making proteins called antibodies to destroy the foreign invaders before they replicate. Once your immune system recognizes a type of foreign cell, it can kill it faster in the future, which is how we acquire immunity. Traditional vaccines, such as those for the measles or the flu, help us develop immunity by introducing a weakened or killed virus into our bodies in a way that allows the immune system to learn how to fight it without making us sick. The new coronavirus vaccines work a little differently.

  • mRNA vaccines contain messenger RNA, which is a type of genetic material that instructs our cells to make certain proteins. In this case, the mRNA tells them to make a harmless version of coronavirus’s “spike” protein. The immune system recognizes these spikes as foreign and begins to build up antibodies. If you are exposed to the real coronavirus later, your body will know how to fight it. The mRNA vaccines do not contain the actual coronavirus, and they cannot make you sick with COVID-19. Once the instructions are delivered, your body disposes of the mRNA.
  • Viral vector vaccines use a harmless version of a virus — not the coronavirus — to deliver instructions. For the COVID-19 vaccine, the modified virus (aka the vector) enters cells and tells them to start making the spike protein that’s unique to the coronavirus. The immune system recognizes the proteins as foreign, attacks them, and builds antibodies. The viral vector vaccine cannot make you sick with COVID-19, nor can you become ill from the virus used as the vector.

COVID-19 vaccine rollout timeline

Who will get the COVID-19 vaccine first?

Pharmacists looking at medications.

Save up to 80% on your medications

Get prescriptions for as low as $4 with our free discount card, redeemable at over 64,000 pharmacies nationwide.

Get free card

Because the supply of COVID-19 vaccines is still somewhat limited, the CDC is working with state and local jurisdictions to implement a vaccination plan. According to their vaccination playbook, critical populations are receiving the vaccine first. This includes health care personnel, essential workers, people at a high risk of developing COVID-19 (such as nursing home residents), and people at a high risk of transmitting COVID-19 (such as those whose work involves unavoidable close contact with other people.)

Rollout across the country will be gradual as vaccine manufacturers work to produce as much as possible as fast as possible. Health care workers are among the first to be vaccinated, while young, healthy, nonessential workers might not have access to a vaccine until later in 2021.

Pay attention to your state’s announcements about when vaccines are available and who is encouraged to get vaccinated, knowing that not everyone will be able to be vaccinated at once.

[us_map]To find the latest information on vaccine eligibility where you live, just click on your state on the map. You’ll be connected directly to your state’s health department.

The CDC has made its implementation recommendations with the following goals in mind:

  • Decrease death and serious disease as much as possible
  • Preserve the functioning of society
  • Reduce the extra burden COVID-19 is having on people already facing disparities

Currently, the COVID-19 vaccine rollout is being implemented in phases 1a, 1b and 1c:

Phase 1a

  • Health care personnel who care for COVID-19 and other patients, and long-term care facility residents

Phase 1b

  • Frontline essential workers who keep the economy moving, including firefighters, police officers, corrections officers, food and agricultural workers, Unites States Postal Service workers, manufacturing workers, grocery store workers, public transit workers, teachers, day care providers and support staff
  • People age 75 and older who are not residents of long-term care facilities but are at a high risk of hospitalization, illness and death from COVID-19

Phase 1c

  • People ages 65 to 74 who are not residents of long-term care facilities
  • People ages 16 to 64 with underlying medical conditions that increase the risk of serious, life-threatening complications from COVID-19
  • Other essential workers, such as people who work in housing construction, finance, information technology, communications, energy, law, media or public health

As availability increases, vaccination recommendations will expand to include more groups. The goal is for everyone to quickly get a COVID-19 vaccination as soon as enough vaccine quantities are available.

Does the vaccine work immediately?

Both the Pfizer-BioNTech and Moderna vaccines require 2 shots to protect against the coronavirus effectively. After the second shot, it takes about 2 weeks for the body to build immunity to the virus. The Johnson & Johnson vaccine requires only 1 dose. Immunity also takes a couple of weeks to build. Once you’re fully vaccinated, follow the most recent CDC guidelines for masking and social distancing, depending on whether you’re in public or in a private setting. These efforts can keep our communities healthy and keep intensive care units from being overwhelmed while the vaccine rollout continues across the country.

Visit the CDC website to get the most up-to-date COVID-19 information.